Korbel Gregory Alan (CIK 0001789032)

Latest company ownership

Shares held
35,700
Last filed at
Aug 1, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 3, 2022 Jun 7, 2022 Aprea Therapeutics, Inc. COO Sell 47.5 -8,390 -28.11% ✗ $6.8K
Mar 10, 2022 Mar 14, 2022 Aprea Therapeutics, Inc. SVP, Chief Business Officer Sell 90.0 +14,011 88.45% ✗ $3.6K
Feb 25, 2022 Mar 1, 2022 Aprea Therapeutics, Inc. SVP, Chief Business Officer Sell 47.5 -1,326 -7.72% ✗ $2.3K
Dec 1, 2021 Dec 3, 2021 Aprea Therapeutics, Inc. SVP, Chief Business Officer Sell 10.0 -27,500 -61.57% ✓ $108.9K
Nov 1, 2021 Nov 3, 2021 Aprea Therapeutics, Inc. SVP, Chief Business Officer Sell 10.0 -27,500 -61.57% ✓ $137.5K
Oct 1, 2021 Oct 5, 2021 Aprea Therapeutics, Inc. SVP, Chief Business Officer Sell 10.0 -27,500 -61.57% ✓ $134.5K
Sep 20, 2021 Sep 22, 2021 Aprea Therapeutics, Inc. SVP, Chief Business Officer Sell 10.0 -32,960 -48.98% ✓ $163.9K
Sep 10, 2021 Sep 14, 2021 Aprea Therapeutics, Inc. Chief Business Officer Sell 47.5 -1,724 -7.08% ✗ $7.9K
Aug 25, 2021 Aug 27, 2021 Aprea Therapeutics, Inc. Chief Business Officer Sell 47.5 -1,149 -4.51% ✗ $4.6K
Oct 7, 2019 Oct 7, 2019 Aprea Therapeutics, Inc. VP of Business Dev't Buy 90.0 +500 100.00% ✗ $7.5K